ASCO publishes a suite of peer-reviewed journals with content focused on

  • clinical oncology research;
  • issues and insights affecting oncology practice;
  • cancer care, research and care delivery issues unique to countries and settings with limited healthcare resources;
  • biomedical informatics methods and processes applied to cancer-related data, information, and images; and
  • the science and practice of precision oncology.

ASCO’s peer-reviewed journals follow a continuous publication schedule. Below is a select list of the newest content from ASCO’s journals. ASCO will update the list on a near-daily basis, and we encourage you to check this page frequently. Email ASCO’s Media Team to request an embargoed journal article or an interview with a study author.

ASCO occasionally highlights select journal articles in an embargoed press release known as a News Digest or in a Featured Article summary. Sign up to receive communications regarding these articles.

Embargoed until April 25, 4:00 p.m. ET:

Elevated Levels of BRAFV600 Mutant ctDNA and Circulating HGF Are Associated With Poor Prognosis in Patients With Metastatic Melanoma (JCO PO: Original Report)
Matthew J. Wongchenko, et al.
Request this article

Survival Outcomes by TP53 Mutation Status in Metastatic Breast Cancer (JCO PO: Original Report)
Funda Meric-Bernstam, et al.
Request this article

Embargoed until April 24, 4:00 p.m. ET:

Reducing Body Image–Related Distress in Women With Breast Cancer Using a Structured Online Writing Exercise: Results From the My Changed Body Randomized Controlled Trial (JCO: Original Report)
Kerry Sherman, et al.
Request this article

Diabetes After Hormone Therapy in Breast Cancer Survivors: A Case-Cohort Study (JCO: Original Report)
Hatem Hamood, et al.
Request this article

Efficacy, Safety, and Regulatory Approval of Food and Drug Administration–Designated Breakthrough and Nonbreakthrough Cancer Medicines (JCO: Original Report)
Aaron Kesselheim, et al.
Request this article

Embargoed until April 23, 4:00 p.m. ET:

Multicenter Phase IB Trial of Carboxyamidotriazole Orotate and Temozolomide for Recurrent and Newly Diagnosed Glioblastoma and Other Anaplastic Gliomas (JCO: Original Report)
Elena Pentsova, et al.
Request this article

Communication About Prognosis With Adolescent and Young Adult Patients With Cancer: Information Needs, Prognostic Awareness, and Outcomes of Disclosure (JCO: Original Report)
Jennifer Mack, et al.
Request this article

Embargoed until April 20, 4:00 p.m. ET:

Model for Predicting Breast Cancer Risk in Women With Atypical Hyperplasia (JCO: Original Report)
Amy Degnim, et al.
Request this article

Integration of Clinical Variables for the Prediction of Late Distant Recurrence in Patients With Estrogen Receptor–Positive Breast Cancer Treated With 5 Years of Endocrine Therapy: CTS5 (JCO: Original Report)
Mitch Dowsett, et al.
Request this article

Intravenous Chemotherapy Compounding Errors in a Follow-Up Pan-Canadian Observational Study (JOP: Original Contribution)
Rachel E. Gilbert, et al.
Request this article

Perceptions of Continued Smoking and Smoking Cessation Among Patients With Cancer (JOP: Original Contribution)
Lawson Eng, et al.
Request this article

CAFE MOCHA An Integrated Platform for Discovering Clinically Relevant Molecular Changes in Cancer: an Example of Distant Metastasis and Recurrence-linked Classifiers in Head and Neck Squamous Cell Carcinoma (JCO CCI: Original Report)
Binay Panda, et al.
Request this article

Embargoed until April 19, 4:00 p.m. ET:

Diagnosis-to-Treatment Interval Is an Important Clinical Factor in Newly Diagnosed Diffuse Large B-Cell Lymphoma and Has Implication for Bias in Clinical Trials (JCO: Original Report)
Grzegorz Nowakowski, et al.
Request this article

BRAF in Lung Cancers: Analysis of 23,396 Cases Reveals Recurrent BRAF Mutations, Fusions, Kinase Duplications, and Concurrent Alterations (JCO PO: Original Report)
Siraj Ali, et al.
Request this article

ERBB3 Activating Mutations in Small Bowel Adenocarcinomas (JCO PO: Original Report)
Luc Cabel, et al.
Request this article

Real Time Genomic Characterization of Metastatic Pancreatic Neuroendocrine Tumors Has Prognostic Implications and Identifies Potential Germline Actionability (JCO PO: Original Report)
Nitya Raj, et al.
Request this article

Embargoed until April 17, 4:00 p.m. ET:

Late Infection-Related Mortality in Asplenic Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study (JCO: Original Report)
Brent Weil, et al.
Request this article

Randomized Phase II Trial of Fulvestrant Plus Everolimus or Placebo in Postmenopausal Women With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy: Results of PrE0102 (JCO: Original Report)
Noah Kornblum, et al.
Request this article

Embargo Information

The embargo date and time of a journal article coincide with its online publication date and time. Journalists may conduct embargoed interviews with study authors up to one week prior to the online publication date. ASCO takes embargo violations seriously and violations typically result in the loss of journal media privileges for a period of one year and may affect broader ASCO media privileges as well.  Journalists may request embargoed articles. Please direct further questions regarding the embargo policies for ASCO Journals to the Media Team.